Glatiramer

Common brands: Copaxone, Glatopa, Ampyra, Vitamin D, Baclofen (Intrathecal)

Top reporter: Teva Neuroscience, Inc.

Potassium Channel Blocker [EPC]Provitamin D2 Compound [EPC]gamma-Aminobutyric Acid-ergic Agonist [EPC]Benzodiazepine [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
59,181
Total Reports
8,377
Serious Reports
1,245
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.10%)

Patient Demographics

Male
10,913
Female
45,016

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Glatiramer.

# Reaction Reports % of Total
1 MULTIPLE SCLEROSIS RELAPSE 5,137
8.0%
2 INJECTION SITE PAIN 4,918
7.7%
3 DRUG INEFFECTIVE 3,871
6.0%
4 INJECTION SITE REACTION 3,495
5.5%
5 FATIGUE 3,251
5.1%
6 MULTIPLE SCLEROSIS 3,071
4.8%
7 DYSPNOEA 2,892
4.5%
8 FALL 2,494
3.9%
9 INJECTION SITE ERYTHEMA 2,455
3.8%
10 GAIT DISTURBANCE 2,111
3.3%
11 INJECTION SITE MASS 2,065
3.2%
12 PAIN 2,027
3.2%
13 NAUSEA 1,918
3.0%
14 DIZZINESS 1,864
2.9%
15 HEADACHE 1,784
2.8%
16 HYPOAESTHESIA 1,742
2.7%
17 INJECTION SITE SWELLING 1,707
2.7%
18 URTICARIA 1,698
2.7%
19 FLUSHING 1,559
2.4%
20 INJECTION SITE PRURITUS 1,488
2.3%
21 ASTHENIA 1,464
2.3%
22 CHILLS 1,395
2.2%
23 HYPERSENSITIVITY 1,352
2.1%
24 MALAISE 1,282
2.0%
25 TREMOR 1,192
1.9%
26 PRURITUS 1,189
1.9%
27 BALANCE DISORDER 1,181
1.8%
28 PARAESTHESIA 1,170
1.8%
29 INJECTION SITE BRUISING 1,165
1.8%
30 PAIN IN EXTREMITY 1,136
1.8%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.